P & F Program

The Pilot and Feasibility (P and F) Program of the Georgia Center for Diabetes Translation Research is a center-wide activity designed to support investigators in conducting studies that address the priority focal areas of GDTRC’s Cores: Design and Evaluation for Equity, Engagement and Behavior Change for Equity, and Technologies Advancing Translation and Equity. This program serves a pivotal role in catalyzing high-return investments by helping develop junior investigators, attracting transitioning investigators, and significantly growing the breadth and depth of NIH-funded collaborative interdisciplinary diabetes translation research in the Southeast region. The integration across GCDTR’s Cores and the P and F Program ensures that pilot study investigators will be supported by Core Faculty –nationally-recognized experts in their fields– in conducting innovative studies using state-of-the-art technologies, innovative design, and multi-disciplinary evaluation approaches.

Current Funding Opportunities

Micro Grant Rapid Funding Mechanism

This is an ongoing opportunity with no submission deadline.

The Micro Grant Rapid Funding Mechanism (MGRFM) is offered by the Georgia Center for Diabetes Translation Research (GCDTR) to provide timely and critical resources that can be leveraged by investigators for the submission of larger research funding requests. Award amounts range from $500 to $2,000. The MGRFM grants support diabetes translation research leading to the submission of an NIH (preferably) or other extramural research funding application that addresses themes encompassed in GCDTR’s research cores (www.gcdtr.org/core-programs/).

Funds are intended to be used to:

  • Enable a new NIH or other extramural application that is expected to be submitted within the next 6 to 12 months
  • Gather data needed for a scored NIH or other extramural application that is currently being revised for resubmission

Scope:

Funds may be used for salary/wages for other staff (e.g. temporary employee to assist in data collection or analysis), consultant costs, equipment, supplies, study subject incentives, or travel to the study site to meet with study personnel. Requests for other uses may be considered if well justified.

Funds may not be used to fund investigator salary, travel to conferences or publications, nor are they intended for currently-funded GCDTR pilot grantees to acquire additional funding to complete or expand their studies.

Eligibility:

Faculty researchers from Emory University, Morehouse School of Medicine, and Georgia Institute of Technology are eligible to apply for pilot and feasibility funding if they fit in one of the following categories:

  • Junior faculty (e.g., Assistant Professor, Clinical Lecturer, Instructor) with limited current or past research support as PD/PI
  • Established investigators who (a) have no experience in diabetes translation research or (b) are proposing ideas that represent a clear departure from their past research and have a fully-engaged junior-level Co-PI (post-doc or junior faculty)
  • Post-doctoral Fellows with a supporting senior Co-PI / mentor (paid effort for Co-PI/mentor is not allowed)

Application Submission:

A completed application package should be emailed to Jeff Mills, Program Director, at jeff.mills@emory.edu. Any application questions should also be directed to Mr. Mills.

The application package should include:

Deadline:

Rolling. Submissions will be circulated for review by an internal committee and a decision will be made within 2 weeks of application submission. This opportunity is limited to available funding and may be discontinued without notice.

Pilot Grant Program for Center Partner Institution Investigators

GCDTR funds pilot grant proposals in the field of diabetes translation research that advance health equity.

Faculty researchers from Emory University, Morehouse School of Medicine, and Georgia Institute of Technology are eligible to apply provided they fit into one of the following categories:

  • Early career faculty (e.g., Assistant Professor, Clinical Lecturer, Instructor) with limited current or past research support as PD/PI. Because the intent is that the project should lead to a subsequent NIH proposal, faculty should be eligible as a principal investigator for an NIH K or NIH R-level grant application at the time of submission.

  • Established investigators who (a) have no experience in diabetes translation research or (b) are proposing ideas that represent a clear departure from their past research and have a fully engaged junior-level Co-PI (post-doc or junior faculty)

New investigators are a priority for funding. For any questions concerning eligibility, please contact Jeff Mills, Program Director, at jeff.mills@emory.edu

Two levels of funding are available:

  • Preliminary or formative research: This opportunity is for exploratory, feasibility, and formative diabetes health equity studies to generate preliminary data to facilitate a subsequent submission of a research grant for external funding. Examples include, but are not limited to, qualitative field work, community-engaged research for development of research questions, instrument, or assay testing, and secondary data analyses that leverage existing databases for data science, analytics, and modeling. Budget: up to $30,000 for one year.

  • Prospective clinical or community-based studies: This opportunity is for pilot studies addressing diabetes health equity questions using prospective approaches in clinical or community-based settings to create or strengthen preliminary data to facilitate subsequent external grant submissions. A variety of methods may be used, including social, behavioral, clinical and community concepts, evaluations of clinical or innovative interventions, and dissemination and implementation studies. Budget: up to $50,000 for one year.

Important Dates

Pilot grant funding for 2022 is closed. Dates for 2023 will be announced soon, please check back.

Letter of intent:  TBA
Application deadline:  TBA

Application Documents and Instructions

Funding Opportunity Announcement (2022)
Application and Instructions (2022)

For any questions related to this funding opportunity contact Jeff Mills, Program Director, at jeff.mills@emory.edu.

Pilot Grant Program for Technology Core Regional Partner Investigators

Pilot grant funding for 2022 is closed. Dates for 2023 will be announced soon, please check back.

GCDTR's Regional Core on Technologies Advancing Translation and Equity provides funding for pilot grant proposals that identify persistent gaps in technology capabilities and barriers to the successful and equitable adoption and impacts of technologies in diabetes prevention and care. This opportunity is for investigators from the Core's regional partner institutions to conduct exploratory, feasibility, and formative diabetes health equity studies to generate preliminary data to facilitate the submission of a subsequent funding application to NIDDK or other funding sources. Budget:  up to $30,000 for one year.

Faculty researchers from the Jaeb Center for Health Research, University of Florida, University of Miami and University of Tennessee Health Sciences Center are eligible to apply as principal investigator for pilot and feasibility funding:

  • Early career faculty (e.g., Assistant Professor, Clinical Lecturer, Instructor) with limited current or past research support as PD/PI. Because the intent is that the project should lead to a subsequent NIH proposal, faculty should be eligible as a principal investigator for an NIH K or NIH R-level grant application at the time of submission.

  • Established investigators who (a) have no experience in diabetes translation research or (b) are proposing ideas that represent a clear departure from their past research and have a fully engaged junior-level Co-PI (post-doc or junior faculty)

New investigators are a priority for funding. For any questions concerning eligibility, please contact Jeff Mills, Program Director, at jeff.mills@emory.edu.

All projects should fall under the umbrella of T2 – T4 translation research and address diabetes, diabetes complications, prediabetes/metabolic syndrome, or obesity prevention or treatment.

  • T2 Research – translation to patients: Translation and/or implementation of interventions/approaches that have clearly demonstrated efficacy into real world health care settings, communities, and populations at risk with an emphasis on reach and sustainability.

  • T3 Research – translation to practice: Effectiveness, cost effectiveness, and comparative effectiveness studies conducted in practice sites, ensuring the translation of results from clinical studies into clinical practice settings.

  • T4 Research – translation to population: Dissemination and implementation research, which identifies and resolves barriers to implementation of evidence-based guidelines into community practice.

Important Dates

Funding for 2022 is closed. Dates for 2023 will be announced soon, please check back.

Letter of intent:  TBA
Application deadline:  TBA

Application Documents and Instructions

Funding Opportunity Announcement (2022)
Application and Instructions (2022)

For any questions related to this funding opportunity contact Jeff Mills, Program Director, at jeff.mills@emory.edu